Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Consultant Immunologist, Fiona Stanley Hospital
2015 → …
Consultant Immunologist, PathWest Laboratory Medicine WA
2013 → …
Consultant Immunologist, Perth Children’s Hospital
2013 → …
Fingerprint
Dive into the research topics where Michael O'Sullivan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial
Chacón, G. P., Estcourt, M. J., Totterdell, J., Marsh, J. A., Perrett, K. P., Campbell, D. E., Wood, N., Gold, M., Waddington, C. S., Sullivan, M. O., McAlister, S., Curtis, N., Jones, M., McIntyre, P. B., Holt, P. G., Richmond, P. C. & Snelling, T., 10 Jun 2024, (Accepted/In press) In: PLoS Medicine. 21, 6 , e1004414.Research output: Contribution to journal › Article › peer-review
Open Access -
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy
Lloyd, M., Loke, P., Ashley, S., Lozinsky, A. C., Orsini, F., O'Sullivan, M., Gold, M., Quinn, P., Metcalfe, J. & Tang, M. L. K., Apr 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 4, p. 1019-1028.e2 12 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Two-year post-treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy-003 Long-Term (PPOIT-003LT) study
PPOIT-003 study group & O'Sullivan, M. D., Oct 2024, In: Allergy: European Journal of Allergy and Clinical Immunology. 79, 10, p. 2759-2774 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy
Hu, A., Lloyd, M., Loke, P., Chebar Lozinsky, A., O'Sullivan, M., Quinn, P., Gold, M. & Tang, M. L. K., Oct 2023, In: Journal of Allergy and Clinical Immunology: In Practice. 11, 10, p. 3195-3202.e4 12 p.Research output: Contribution to journal › Article › peer-review
-
Early Peanut Immunotherapy in Children (EPIC) trial: Protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age
O'Sullivan, M. D., Bear, N. & Metcalfe, J., 14 Nov 2023, In: BMJ Paediatrics Open. 7, 1, e002294.Research output: Contribution to journal › Article › peer-review
Open Access
Projects
- 1 Finished
-
FHRI COVID-19 VIP project
Salter, S. (Investigator 01), Leeb, A. (Investigator 02), Nissen, L. (Investigator 03), Murray, K. (Investigator 04), O'Sullivan, M. (Investigator 05), Windsor, D. (Investigator 06), Li, D. (Investigator 07), Peters, I. (Investigator 08), Lee, K. (Investigator 09), Seubert, L. (Investigator 10), Orlemann, K. (Investigator 11), Perry, D. (Investigator 12), Smith, D. (Investigator 13) & Singh, G. (Investigator 14)
Department of Health (Western Australia)
18/01/21 → 18/01/23
Project: Research